Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment-Reference-Cited by-同舟云学术

Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment

Published:2017-07-14 Issue:7 Volume:18 Page:1522
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Bignucolo Alessia,De Mattia Elena^ORCID,Cecchin Erika,Roncato Rossana,Toffoli Giuseppe

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/18/7/1522/pdf

Reference101 articles.

1. International Association of Cancer Registrieshttp://iicc.iarc.fr/

2. Epidemiology of colorectal cancer;Marley;Int. J. Mol. Epidemiol. Genet.,2016

3. Adjuvant treatment of colon cancer: What is next?;Van Loon;Curr. Opin. Oncol.,2011

4. Current opinion on optimal treatment for colorectal cancer

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of novel chemical scaffolds against kinase domain of cancer causing human epidermal growth factor receptor 2: a systemic chemoinformatic approach;Journal of Biomolecular Structure and Dynamics;2023-07-09

2. Effect of Secretion Efficiency of Mutant KRAS Neoantigen by Lactococcus lactis on the Immune Response of a Mucosal Vaccine Delivery Vehicle Targeting Colorectal Cancer;International Journal of Molecular Sciences;2023-05-18

3. Predictive and Prognostic Value of Oncogene Mutations and Microsatellite Instability in Locally-Advanced Rectal Cancer Treated with Neoadjuvant Radiation-Based Therapy: A Systematic Review and Meta-Analysis;Cancers;2023-02-25

4. TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1/RIPK3/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer;Cell Death & Disease;2023-01-05

5. Targeted cancer therapy: The future of drug combinations;Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies;2023